Valued at USD 34.46 billion in 2025, the Immunoassay Market is projected to reach USD 36.03 billion in 2026 and USD 50.95 billion by 2034, growing at a CAGR of 4.4% during the forecast period 2026–2034. Key players include Abbott, BD, Beckman Coulter, Inc., bioMérieux, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, QuidelOrtho Corporation, Siemens Healthineers AG, Sysmex Corporation, and Thermo Fisher Scientific Inc. The market is driven by the growing prevalence of chronic and infectious diseases and the growing need for personalized healthcare.

A Rising Disease Burden Underpins Demand

Diabetes, cardiovascular disease, cancer, and autoimmune diseases are on the rise. According to a World Health Organization report cited on the page, noncommunicable diseases accounted for 43 million deaths in 2021, and 75% of non-pandemic deaths. Immunoassays detect disease-associated biomarkers, making them central to chronic disease management and underscoring the need for reliable, advanced technologies in the Immunoassay Market.

Screening for Infectious Threats

The rising incidence of infectious diseases such as HIV, hepatitis, and other viruses has increased the need for effective diagnostics. ELISA tests support early diagnosis, which is important for controlling disease spread. Demand for infectious disease testing is also reflected in the application segmentation, which lists infectious disease testing alongside oncology, cardiology, endocrinology, autoimmune diseases, and therapeutic drug monitoring. Growing demand for reliable tools in infectious diseases, cancer, and autoimmune conditions continues to support ELISA reagents.

Blood Remains the Dominant Specimen

Blood-based immunoassay testing is the most prevalent approach, owing to high biomarker levels in blood and its use in clinical diagnosis. By specimen, the blood segment saw significant market growth in 2025 across hospitals, clinics, and laboratories, with saliva and urine as other segments. Advances in microfluidic technology are gaining popularity in point-of-care and clinic settings; for example, HemaXis developed a micro blood sampling platform that collects and prepares precise amounts of whole blood, plasma, and serum for faster results.

Read More @ https://www.polarismarketresearch.com/industry-analysis/immunoassay-market

Platform and Analyzer Innovation

Technology segmentation includes enzyme immunoassays, which encompass chemiluminescence immunoassays and fluorescence immunoassays, alongside radioimmunoassay and rapid tests. In January 2025, Anbio Biotechnology launched a dry chemiluminescence solution for clinical settings. Among immunoassay analyzers, Abbott’s ARCHITECT i1000SR offers high-throughput, accurate biomarker screening, while Beckman Coulter introduced the compact DxC 500i Analyzer in July 2024 for clinical chemistry and immunoassays. Bio-Rad’s EQAS Specialty Immunoassay program, launched in October 2024, consolidates 13 analytes to streamline proficiency testing. The page segments immunoassay analyzers into open-ended and closed-ended systems.

Emerging Economies Expand Access

Developing countries such as India and Thailand are investing heavily in hospitals, diagnostic facilities, and clinics. In India, public spending on healthcare increased by 37% from 2020-21 to 2021-22. Asia Pacific governments are also raising healthcare budgets to enhance diagnostic capabilities, which could make immunoassays more mainstream in routine checks and early detection. Asia Pacific is expected to record the highest growth rate, while North America held the largest share in 2025.

Restraints B2B Buyers Should Weigh

Reimbursement policies, costly instruments, and complexities in some regions continue to inhibit growth, particularly in low- and middle-income countries. The report’s table of contents also lists stringent regulation in product development and validation as a restraint on the Immunoassay Market.

More Trending Latest Reports By Polaris Market Research:

battery-market

sports-nutrition-market

top-5-companies-driving-change-in-tampon-manufacturing

intelligent-building-automation-technologies-market

polycarbonate-sheet-market

unsaturated-polyester-resins-market

donkey-milk-market

ground-based-air-defense-systems-market

3d-printing-filaments-market